Long-term Outcome of Perioperative Low Cardiac Output Syndrome in Cardiac Surgery: 1-year Results of a Multicenter Randomized Trial

Aprotinin and Hemostasis Monitoring Concerns During Cardiac Surgery

Aprotinin (Trasylol) is a serine protease inhibitor, isolated from bovine lung that initially was marketed for the treatment of pancreatitis. In the mid 1980s, reports of its ability to decrease hemorrhaging after cardiopulmonary bypass surgery introduced the drug to the realm of cardiac surgery.